logo
Select company
Select metric
$ -1.04EBITDA per Share
VS
Market
18
Sector
46
Industry
61
History
88
$ 1.02Close
$ 0.85 - $ 4.86 52-Week Range
Ticker Information

Ticker

MRKR

Company Name

MARKER THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

MARKER THERAPEUTICS INC - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

MRKR - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -14.56M$ -1.04113.96M
3/31/2025$ -12.73M$ -1.15111.11M
12/31/2024$ -10.68M$ -1.1918.98M
9/30/2024$ -9.69M$ -1.0918.92M
6/30/2024$ -10.37M$ -1.1618.92M
3/31/2024$ -6.63M$ -0.7418.9M
12/31/2023$ -8.23M$ -0.9318.81M
9/30/2023$ -8.33M$ -0.9418.83M
6/30/2023$ -11.22M$ -1.2818.8M
3/31/2023$ -21.17M$ -2.4318.72M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • MARKER THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDAPS stands at $ -5.25.
  • Over the past 5 years, MARKER THERAPEUTICS INC's average EBITDAPS has been $ -2.91.
  • The median EBITDAPS for MARKER THERAPEUTICS INC during this period was $ -2.79
  • MARKER THERAPEUTICS INC reached its highest EBITDAPS over the past 5 years at $ -0.74.
  • The lowest EBITDAPS recorded by MARKER THERAPEUTICS INC in the same timeframe $ -5.87

MARKER THERAPEUTICS INC's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
LPCN : LIPOCINE INC $ -0.83BOLT : BOLT BIOTHERAPEUTICS INC $ -24.58XAIR : BEYOND AIR INC $ -7.15TRAW : TRAWS PHARMA INC $ 15.1INM : INMED PHARMACEUTICALS INC $ -7.43LGVN : LONGEVERON INC $ -1.16LEXX : LEXARIA BIOSCIENCE CORP $ -0.62NBY : NOVABAY PHARMACEUTICALS INC $ 0.62NRXS : NEURAXIS INC $ -0.82IBIO : IBIO INC $ -1.62

Similar metrics to Shares WA:

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS EBITDAPS for MARKER THERAPEUTICS INC is calculated as follows: EBITDA [ $ -24.59M ] / (Shares WA [ 4.69M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ -5.25 ]

MRKR - EBITDA per Share, Last 5 years

$ -5.87

Minimum

Dec 31, 2020

$ -0.74

Maximum

Mar 31, 2024

$ -2.91

Average

$ -2.79

Median

EBITDAPS Benchmark Analysis

 The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.03 with a standard deviation of $ 4.28.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -11.29
max$ 14.03
average$ 2.03
median$ 1
std$ 4.28